Literature DB >> 25951528

Duodenal energy sensing regulates hepatic glucose output.

Brennan K Smith1, Gregory R Steinberg2.   

Abstract

Entities:  

Year:  2015        PMID： 25951528     DOI： 10.1038/nm.3859

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.

Authors:  Clémence D Côté; Brittany A Rasmussen; Frank A Duca; Melika Zadeh-Tahmasebi; Joseph A Baur; Mira Daljeet; Danna M Breen; Beatrice M Filippi; Tony K T Lam
Journal:  Nat Med       Date:  2015-04-06       Impact factor: 53.440

Review 2.  Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.

Authors:  Ruben Nogueiras; Kirk M Habegger; Nilika Chaudhary; Brian Finan; Alexander S Banks; Marcelo O Dietrich; Tamas L Horvath; David A Sinclair; Paul T Pfluger; Matthias H Tschöp
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.

Authors:  Marc Foretz; Sophie Hébrard; Jocelyne Leclerc; Elham Zarrinpashneh; Maud Soty; Gilles Mithieux; Kei Sakamoto; Fabrizio Andreelli; Benoit Viollet
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

4.  Metformin action: concentrations matter.

Authors:  Ling He; Fredric E Wondisford
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

5.  Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.

Authors:  Frank A Duca; Clémence D Côté; Brittany A Rasmussen; Melika Zadeh-Tahmasebi; Guy A Rutter; Beatrice M Filippi; Tony K T Lam
Journal:  Nat Med       Date:  2015-04-06       Impact factor: 53.440

Review 6.  Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review.

Authors:  A Natali; E Ferrannini
Journal:  Diabetologia       Date:  2006-02-14       Impact factor: 10.122

7.  Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.

Authors:  Kai Liu; Rui Zhou; Bin Wang; Man-Tian Mi
Journal:  Am J Clin Nutr       Date:  2014-04-02       Impact factor: 7.045

8.  Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.

Authors:  Russell A Miller; Qingwei Chu; Jianxin Xie; Marc Foretz; Benoit Viollet; Morris J Birnbaum
Journal:  Nature       Date:  2013-01-06       Impact factor: 49.962

9.  AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol.

Authors:  Jee-Hyun Um; Sung-Jun Park; Hyeog Kang; Shutong Yang; Marc Foretz; Michael W McBurney; Myung K Kim; Benoit Viollet; Jay H Chung
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

10.  Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.

Authors:  Morgan D Fullerton; Sandra Galic; Katarina Marcinko; Sarah Sikkema; Thomas Pulinilkunnil; Zhi-Ping Chen; Hayley M O'Neill; Rebecca J Ford; Rengasamy Palanivel; Matthew O'Brien; D Grahame Hardie; S Lance Macaulay; Jonathan D Schertzer; Jason R B Dyck; Bryce J van Denderen; Bruce E Kemp; Gregory R Steinberg
Journal:  Nat Med       Date:  2013-11-03       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.